NIH-funded research R01 grant

Identifying biomarkers to improve kidney transplant outcomes in children and young adults

Official title: Clinical and Molecular Biomarkers of Endpoints in Pediatric Renal Transplantation

Funded at University of Alabama at Birmingham · NIH-10911231 · Data updated 2026-11-12

This study is looking for ways to help kids and young adults who have had kidney transplants live longer and healthier by finding special signs that can predict how well their transplant will work.

More Renal Transplantation research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startSeptember 15, 2020
Project endAugust 31, 2025
Funding year2024
Award (this year)$285,120
NIH project number5R01DK126807-05
Project IDNIH-10911231 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are pediatric and young adult patients undergoing kidney transplantation or those who have received a transplant.

Less likely to help

Patients who are not undergoing kidney transplantation or are outside the pediatric and young adult age range may not benefit from this research.

What this research studies

This research focuses on improving the survival rates of kidney transplants in pediatric and young adult patients by identifying clinical and molecular biomarkers that can predict transplant outcomes. The study aims to develop better diagnostic tools that are specifically tailored for younger patients, addressing the unique challenges they face. By integrating clinical features with traditional histology and molecular biomarkers, the research seeks to enhance early detection of kidney transplant injuries, potentially leading to more effective interventions. The ultimate goal is to increase the longevity and quality of life for young individuals with end-stage renal disease.

Why it matters

Potential benefit: If successful, this research could significantly improve the long-term success of kidney transplants in children and young adults, enhancing their life expectancy and quality of life.

How similar studies have gone: Previous studies in adult populations have shown success in using molecular biomarkers for kidney transplant outcomes, but this approach is novel for pediatric patients.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Seifert, Michael Edward — University of Alabama at Birmingham
  • Study coordinator: Seifert, Michael Edward

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.